Akela Pharma has announced completion of a private placement totaling $2,310,000 that it will use primarily for expansion of spray drying and hot melt extrusion capabilities at its subsidiary, PharmaForm. Although PharmaForm specializes in solid dosage forms, it also offers services for nasal sprays and dry powder formulation development. The parent company, … [Read more...] about Akela gets funding for its PharmaForm subsidiary
Business
Team Consulting opens new respiratory physics laboratory
Team Consulting has announced the opening of its new Respiratory Physics Laboratory at the company headquarters in Ickleton, Cambridgeshire, UK. Recent hire Mark Shepherd will manage the cGMP laboratory. “In recent years we have worked for six of the world’s top ten pharma companies and for them it is important to see us making this investment in facilities and … [Read more...] about Team Consulting opens new respiratory physics laboratory
New inhalation consortium formed in Scandinavia
The new Medicon Valley Inhalation Consortium (MVIC) includes seven inhalation technology companies located in the Skåne-Copenhagen region of Scandinavia. According to the consortium, it "will work to globally promote Medicon Valley as an international center of inhalation competence and offer a comprehensive set of world class services." Many of the member … [Read more...] about New inhalation consortium formed in Scandinavia
Recall of acetylcysteine inhalation solution
Bedford Laboratories has announced a national (US) voluntary product recall of acetylcysteine solution manufactured for Roxane Laboratories. The recall was initiated on December 20, 2011 due to a visible glass particle in a vial of solution from lot 1877093. According to the company, no adverse events have been reported. The company warned that "Use of an inhaled … [Read more...] about Recall of acetylcysteine inhalation solution
Impax acquires rights to Zomig nasal spray
California-based Impax Pharmaceuticals has acquired exclusive US rights to several dosage forms of Zomig zolmitriptan, including the nasal spray formulation, from AstraZeneca. Zomig nasal spray is approved in the US for the treatment of migraine headaches. The agreement also gives Impax non-exclusive rights to develop and commercialize new zolmitriptan products. … [Read more...] about Impax acquires rights to Zomig nasal spray
Valeant withdraws offer for ISTA
After having its first offer rejected by ISTA Pharmaceuticals, and after ISTA indicated that an increased offer was still insufficient, Valeant Pharmaceuticals has withdrawn its offer of $7.50 per share a day before its announced deadline of January 31, 2012. ISTA has several bepotastine nasal sprays in development for the treatment of allergic rhinitis. Valeant … [Read more...] about Valeant withdraws offer for ISTA
Company to launch THC e-cigarette in US
A company called Rapid Fire Marketing says that its subsidiary Medical Cannabis Management is launching a tetrahydrocannabinol (THC) e-cigarette in the US immediately and will follow with a second-generation device in 30-60 days. The device, called the CannaCig, is designed to deliver THC "in an oil form," according to the company, and will be sold through physicians … [Read more...] about Company to launch THC e-cigarette in US
Almirall and Galapagos partner to find new respiratory drug candidates
Spanish pharmaceutical company Almirall and Belgian biotech Galapagos have entered into a three-year agreement "aimed at delivering drug development candidates directed to a key respiratory target of interest to Almirall." According to the companies, the deal could be worth €7.5 million to Galapagos subsidiary BioFocus, which will be doing the research. Almirall's … [Read more...] about Almirall and Galapagos partner to find new respiratory drug candidates
Aptar opens new nasal/pulmonary device manufacturing facility in India
Aptar Pharma has opened a new manufacturing facility in Rabale, Navi Mumbai, India, where it will produce the DF30 metering valve for pressurized metered dose inhalers (MDIs) and spray pump assemblies for nasal spray delivery. The site was officially declared open on January 21, 2012 with a ceremony attended by the president of the Indian Pharmaceutical Association … [Read more...] about Aptar opens new nasal/pulmonary device manufacturing facility in India
Meda files patent infringement suit against Apotex, Perrigo
Meda Pharmaceuticals has filed a patent infringement suit against Apotex and Perrigo in US District Court in regard to their generic versions of its Astepro azelastine nasal spray for the treatment of rhinitis. The suit alleges infringement of a patent granted to Meda in December 2011 when the two companies submitted abbreviated new drug applications for generic … [Read more...] about Meda files patent infringement suit against Apotex, Perrigo